Chemosensitivity differences between primary and metastatic lesions of clinical gastric cancer

H. Kusumoto, Y. Maehara, T. Kusumoto, H. Anai, K. Akazawa, K. Sugimachi

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)

Abstract

An in vitro chemosensitivity test, the succinate dehydrogenase inhibition (SDI) test, was used to examine 16 pairs of samples obtained simultaneously from primary and metastatic lesions of clinical gastric cancer. Concerning the metastases, 11 were in the lymph nodes and five in the liver. The chemosensitivities of metastatic lesions against six anti-tumour drugs, carboquone (CQ), adriamycin (ADM), mitomycin C (MMC), aclacinomycin A (ACR), and 5-fluorouracil (5-FU), differed from those in the primary lesions, and there were no correlations of chemosensitivities between the primary and the metastatic lesions against these drugs, except for DDP. The lymph nodes were more sensitive to CQ, ADM, MMC, DDP, ACR and 5-FU, while the liver was less sensitive than the primary lesions to CQ, ADM, MMC, DDP and ACR. Our findings indicate that in patients with lymph node metastasis, there is a sensitivity to anti-tumour drugs, while in cases of liver metastasis, drug treatment may be less effective. We propose that chemosensitivity testing should be done when attempting to design anti-tumour drugs.

Original languageEnglish
Pages (from-to)685-689
Number of pages5
JournalEuropean Journal of Surgical Oncology
Volume14
Issue number6
Publication statusPublished - 1988
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Chemosensitivity differences between primary and metastatic lesions of clinical gastric cancer'. Together they form a unique fingerprint.

Cite this